Compact synthetic Fe(II) warhead lets an RNA-binding small molecule cleave toxic CUG repeats in DM1 cells
- A small, fully synthetic Fe(II)-binding cleaving group is tested as a substitute for bulky natural-product warheads such as bleomycin.
- Attached to a ligand that recognizes expanded r(CUG) repeats, it degrades the pathogenic RNA while leaving wild-type and short-repeat transcripts largely intact.
- In DM1 patient myoblasts, this lowered nuclear foci, MBNL1 sequestration and splicing defects, with no DNA damage reported.
💡 Points Based on the abstract
Selectivity here comes from the ligand, not the warhead: Fe-based cleavers make diffusible radicals, so any RNA or DNA near the bound molecule is at risk, and a no-DNA-damage claim needs transcriptome-wide data. The key missing control is a non-binding ligand analog carrying the same warhead. A fair comparison would be potency per cell exposure against a RIBOTAC-style recruiter on the same CUG ligand.